CV NASDAQ
CapsoVision, Inc.
1W: -7.3%
1M: +13.6%
3M: +44.7%
YTD: -33.9%
$6.64
-0.13 (-1.92%)
Weekly Expected Move ±11.3%
$5
$6
$6
$7
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
1 bullish
0 neutral
1 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (20)
12 Health Care Stocks Moving In Monday's After-Market Session
UnitedHealth, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
Benchmark updates its best ideas list
CapsoVision targets 510(k) submission for Gen 2 Colon capsule and AI module in Q3 2026 as commercial adoption accelerates
CapsoVision, Inc. reports Q4 results
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results
Earnings Scheduled For March 26, 2026
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Thursday's After-Market Session
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026
CapsoVision to Participate in the 38th Annual ROTH Conference
CapsoVision, Inc. (NASDAQ:CV) Short Interest Update
CapsoVision (NASDAQ:CV) Shares Gap Down – What’s Next?
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus
CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell?
CapsoVision, Inc.’s Lock-Up Period Set To End on December 29th (NASDAQ:CV)
CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference